Hologic manufactures proprietary products for the healthcare needs of women... Show more
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where HOLX declined for three days, in of 292 cases, the price declined further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on April 04, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on HOLX as a result. In of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Aroon Indicator for HOLX entered a downward trend on April 15, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 53 cases where HOLX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for HOLX just turned positive on April 23, 2025. Looking at past instances where HOLX's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HOLX advanced for three days, in of 320 cases, the price rose further within the following month. The odds of a continued upward trend are .
HOLX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock slightly better than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HOLX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.839) is normal, around the industry mean (23.728). P/E Ratio (36.076) is within average values for comparable stocks, (81.831). Projected Growth (PEG Ratio) (1.425) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (4.728) is also within normal values, averaging (41.794).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
a manufacturer of diagnostics products, medical imaging systems and surgical products
Industry MedicalSpecialties
A.I.dvisor indicates that over the last year, HOLX has been loosely correlated with BDX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if HOLX jumps, then BDX could also see price increases.
Ticker / NAME | Correlation To HOLX | 1D Price Change % | ||
---|---|---|---|---|
HOLX | 100% | -0.07% | ||
BDX - HOLX | 51% Loosely correlated | +1.22% | ||
ZBH - HOLX | 45% Loosely correlated | +2.06% | ||
ABT - HOLX | 45% Loosely correlated | -1.43% | ||
DGX - HOLX | 44% Loosely correlated | +0.42% | ||
CNMD - HOLX | 40% Loosely correlated | +3.52% | ||
More |